Slingshot members are tracking this event:

AstraZeneca's (AZN) Phase 3 KESTREL and EAGLE Clinical Trials for Durvalumab in Head and Neck Cancer Suspended by FDA

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 27, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Kestrel, Eagle, Durvalumab, Head And Neck Cancer, Fda, Trial Suspension, Bleeding